Johnson & Johnson Ordered to Pay $8 Billion in Risperdal Case Involving Male Breast Growth

Published: 9/10/2019
Johnson & Johnson Ordered to Pay $8 Billion in Risperdal Case Involving Male Breast Growth
Source: GIZMODO.COM

Johnson & Johnson has been ordered to pay $8 billion in punitive damages in a case involving the way that the anti-psychotic drug Risperdal was marketed. Some male patients have argued that the drug caused them to grow large breasts and that the company downplayed this side effect when marketing the drug to doctors. Read more...

Read more
Related news
Comment
FACEBOOK